Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mette P. Myklebust"'
Autor:
Havjin Jacob, Luka Stanisavljevic, Kristian Eeg Storli, Kjersti E. Hestetun, Olav Dahl, Mette P. Myklebust
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Abstract About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological
Externí odkaz:
https://doaj.org/article/9dd3caffa57b43dc8719f849893eb89b
Autor:
Olav Dahl, Mette Pernille Myklebust
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: MicroRNA (MiR) influences the growth of cancer by regulation of mRNA for 50–60% of all genes. We present as per our knowledge the first global analysis of microRNA expression in anal cancer patients and their prognostic impact. Methods
Externí odkaz:
https://doaj.org/article/c3b2eb1cdf764e089cee52fce6978ecc
Autor:
Kjersti Elvestad Hestetun, Nina Benedikte Rosenlund, Luka Stanisavljević, Olav Dahl, Mette Pernille Myklebust
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionDeficient mismatch repair (dMMR) or high microsatellite instability (MSI-H) is associated with an improved prognosis in colon cancer stage II but poor prognosis in stage IV colon cancer. The clinical significance of dMMR in colon cancer s
Externí odkaz:
https://doaj.org/article/9cd6bd6de8d5484f8dfce4fe150d5ed4
Autor:
Mette Pernille Myklebust, Benedikte Rosenlund, Peder Gjengstø, Bogdan Stefan Bercea, Ása Karlsdottir, Marianne Brydøy, Olav Dahl
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
Cell-free microRNAs have been reported as biomarkers for several diseases. For testicular germ cell tumors (GCT), circulating microRNAs 371a-3p and 372-3p in serum and plasma have been proposed as biomarkers for diagnostic and disease monitoring purp
Externí odkaz:
https://doaj.org/article/24b0b524b4ec476c829e195d5d10aa44
Autor:
Mette Pernille Myklebust, Anna Thor, Benedikte Rosenlund, Peder Gjengstø, Ása Karlsdottir, Marianne Brydøy, Bogdan S. Bercea, Christian Olsen, Ida Johnson, Mathilde I. Berg, Carl W. Langberg, Kristine E. Andreassen, Anders Kjellman, Hege S. Haugnes, Olav Dahl
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract MicroRNA-371a-3p (miR371) has been suggested as a sensitive biomarker in testicular germ cell cancer (TGCC). We aimed to compare miR371 with the classical biomarkers α-fetoprotein (AFP) and β-human chorionic gonadotropin (hCGβ). Overall,
Externí odkaz:
https://doaj.org/article/007a32cb6b57433c9a8d6a521c3627cb